Mail

UK markets close in 1 hour 7 minutes

FTSE 100
8,212.16
-13.17(-0.16%)
FTSE 250
20,352.33
+54.23(+0.27%)
AIM
764.88
-1.04(-0.14%)
GBP/EUR
1.1808
-0.0008(-0.07%)
GBP/USD
1.2654
+0.0030(+0.24%)
Bitcoin GBP
49,157.75
+378.35(+0.78%)

Trending tickers

Amazon, Apple, Micron, Tesla

AI fever sets the tone for big tech stocks and chipmakers

Active Biotech AB (publ) (ACTIS.XC)

Cboe UK - Cboe UK Real-time price. Currency in SEK

Add to watchlist

1.9000

-1.9000

(-100.00%)

As of 08:03AM BST. Market open.

Currency in SEK

Valuation measures⁴

Market cap (intra-day)	177.11M
Enterprise value	145.43M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	51.97
Price/book (mrq)	15.98
Enterprise value/revenue	45.75
Enterprise value/EBITDA	-3.23

Trading information

Stock price history

Beta (5Y monthly)	0.55
52-week change ³	0.00%
S&P500 52-week change ³	24.60%
52-week high ³	1.7200
52-week low ³	0.0000
50-day moving average ³	1.7200
200-day moving average ³	1.7200

Share statistics

Avg vol (3-month) ³	N/A
Avg vol (10-day) ³	N/A
Shares outstanding ⁵	265.14M
Implied shares outstanding ⁶	265.14M
Float ⁸	172.52M
% held by insiders ¹	45.32%
% held by institutions ¹	14.89%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2022
Most-recent quarter (mrq)	30 Jun 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-112.77%
Return on equity (ttm)	-354.67%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-51.98M
Net income avi to common (ttm)	-51.07M
Diluted EPS (ttm)	-0.2100
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	15.7M
Total cash per share (mrq)	0.06
Total debt (mrq)	3.7M
Total debt/equity (mrq)	31.09%
Current ratio (mrq)	2.04
Book value per share (mrq)	0.05

Cash flow statement

Operating cash flow (ttm)	-50.45M
Levered free cash flow (ttm)	-31.63M